Evidence map›Paper›PMID 33859745›Full record

ArticleTheranostics2021

Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury.

Jing-Yuan Cao, Bin Wang, Tao-Tao Tang, Yi Wen, Zuo-Lin Li, Song-Tao Feng, Min Wu, Dan Liu, Di Yin, Kun-Ling Ma and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 191 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
191citing papers in PubMed, 1 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

191 citing papers in PubMed, 1 synthesis or guideline pooled it, 293 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Protective Effects and Mechanisms of Extracellular Vesicles in Remote Ischemic Preconditioning on Renal Injury Induced by Inflammation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Integrative Approaches to Treating Cellular Senescence in Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  20. Review

131 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Jing-Yuan CaoInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Bin WangInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Tao-Tao TangInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Yi WenInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Zuo-Lin LiInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Song-Tao FengInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Min WuInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Dan LiuInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Di YinInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Kun-Ling MaInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Ri-Ning TangInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Qiu-Li WuInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Hui-Yao LanDepartment of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, Liu Che Woo Institute of Innovative Medicine, Chinese University of Hong Kong, Hong Kong SAR 999077, China.
Lin-Li LvInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Bi-Cheng LiuInstitute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China.
Zhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells-derived exosomes (MSC-exos) have attracted great interest as a cell-free therapy for acute kidney injury (AKI). However, the

Indexed as

Acute Kidney InjuryAnimalsApoptosisbcl-2-Associated X ProteinCDC2 Protein KinaseCell Cycle CheckpointsCell DivisionCell LineCell ProliferationCyclin B1Epithelial CellsExosomesG2 PhaseHumansIschemiaKidney Tubules, Proximalbcl-2-Associated X ProteinCDC2 Protein KinaseCyclin B1MicroRNAsMirn125 microRNA, mouseProto-Oncogene Proteins c-bcl-2TP53 protein, humanTumor Suppressor Protein p53acute kidney injuryexosomesmesenchymal stem cellmiR-125b-5ptubular repair

Identifiers

PMID33859745
PMCPMC8039965
OpenAlexW3139526136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.